ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
DOSE Rapid Dose Therapeutics Corp
- 0.230
- 0.0000.00%
15min DelayMarket Closed Dec 13 15:30 ET
29.40MMarket Cap-5.75P/E (TTM)
0.240High0.230Low23.50KVolume0.230Open0.230Pre Close5.54KTurnover0.32552wk High0.02%Turnover Ratio127.82MShares0.09052wk Low-0.04EPS TTM26.44MFloat Cap1.330Historical HighLossP/E (Static)114.95MShs Float0.025Historical Low-0.04EPS LYR4.35%Amplitude--Dividend TTM-7.93P/B1Lot Size--Div YieldTTM
Rapid Dose Therapeutics Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -42.62%-261.31K | -368.73%-622.31K | -165.65%-2.29M | -1,338.90%-1.29M | -466.86%-672.67K | 48.64%-183.23K | 46.70%-132.77K | 71.20%-863.92K | 10.57%-89.74K | 82.77%-118.67K |
| Net income from continuing operations | -50.50%-1.1M | -121.71%-1.26M | -13.03%-4.31M | -57.57%-2.05M | -68.14%-981.08K | 20.10%-730.69K | 43.79%-566.88K | 55.11%-3.81M | 81.18%-1.3M | 26.21%-583.5K |
| Operating gains losses | ---- | ---- | --558.81K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -64.18%50.22K | -43.53%82.73K | -1.14%620.31K | -36.41%180.77K | 36.46%152.84K | 21.28%140.19K | 26.75%146.51K | -18.07%627.44K | -7.59%284.26K | -26.73%112K |
| Remuneration paid in stock | --0 | ---- | -120.85%-5.97K | ---- | ---- | --32.12K | ---- | -79.02%28.62K | ---- | ---- |
| Remuneration paid in stock | --241.94K | --426.7K | -77.05%162.25K | 200.30%162.25K | --0 | --0 | --0 | -58.32%706.93K | -96.16%54.03K | -10.24%140.69K |
| Other non cashItems | 443.16%238.44K | 1,552.68%226.3K | 54.93%187.42K | -57.69%48.08K | 1,797.66%91.01K | 237.37%43.9K | 2.03%13.69K | 873.49%120.98K | 262.58%113.64K | --4.8K |
| Change In working capital | -7.10%307.76K | -136.95%-101.2K | -66.58%488.68K | -124.69%-181.07K | -68.86%64.56K | 57.35%331.26K | -20.91%273.91K | 221.06%1.46M | -22.77%733.36K | 199.99%207.36K |
| -Change in receivables | 97.46%-1.26K | -141.46%-16.86K | -418.48%-67.32K | -1,001.62%-128.84K | 318.08%70.45K | -201.90%-49.6K | 57.00%40.67K | -89.57%21.14K | -95.56%14.29K | 28.62%-32.31K |
| -Change in inventory | -16.15%36.73K | 43.30%-19.73K | -83.98%12.58K | -98.05%1.84K | -92.77%1.74K | 237.02%43.81K | 33.93%-34.8K | 298.17%78.58K | 393.93%94.2K | -34.84%24.05K |
| -Change in prepaid assets | -428.84%-43.57K | -192.88%-23.88K | -209.72%-64.54K | -23.19%55.78K | -452.54%-159.28K | 4,214.29%13.25K | 67.37%25.71K | 372.55%58.83K | 553.22%72.61K | -128.98%-28.83K |
| -Change in payables and accrued expense | -4.71%315.85K | -116.42%-40.73K | -52.71%621.26K | -119.59%-109.85K | -38.35%151.65K | 122.21%331.47K | -30.68%247.97K | 379.29%1.31M | 43.74%560.77K | 369.87%245.97K |
| -Change in other working capital | ---- | ---- | -32.39%-13.3K | --0 | ---- | ---7.66K | ---5.64K | 98.86%-10.05K | -104.10%-8.51K | 99.26%-1.54K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -42.62%-261.31K | -368.73%-622.31K | -165.65%-2.29M | -1,338.90%-1.29M | -466.86%-672.67K | 53.28%-183.22K | 46.70%-132.77K | 71.20%-863.92K | -558.58%-89.74K | 82.77%-118.67K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -51.54%219.93K | 316.22%574.32K | 183.52%2.43M | 1,314.22%1.29M | 393.78%635.42K | 12.49%453.84K | -37.42%137.98K | -24.02%856.53K | 104.66%90.94K | -57.43%128.69K |
| Net issuance payments of debt | -121.58%-89.07K | -121.12%-29.14K | 170.84%1.22M | -3,027.09%-169.02K | 199.51%385.42K | 2.31%412.75K | 256.77%137.98K | 258.12%451.68K | -29.62%-5.41K | 278.46%128.69K |
| Net common stock issuance | --309K | --580.53K | 693.65%1.21M | 1,968.77%1.21M | --0 | --0 | --0 | --151.85K | 107.55%58.25K | --0 |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | --0 | --107.79K | ---- | ---- | ---- | --0 |
| Net other financing activities | ---- | --22.93K | ---- | ---- | --250K | ---166.7K | ---- | 94.62%253K | 104.34%90K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -37.84%219.93K | 316.22%574.32K | 183.52%2.43M | 1,314.22%1.29M | 393.78%635.42K | -12.30%353.84K | -37.42%137.98K | -24.02%856.53K | 104.70%90.94K | -57.43%128.69K |
| Net cash flow | ||||||||||
| Beginning cash position | 244.65%113.06K | 483.82%161.06K | -19.90%27.59K | 530.26%166.18K | 1,157.65%203.43K | 561.39%32.81K | -19.90%27.59K | -50.98%34.44K | -77.20%26.37K | -96.96%16.18K |
| Current changes in cash | -124.25%-41.38K | -1,019.84%-48K | 1,906.36%133.47K | -525.33%-5.12K | -471.67%-37.25K | 1,411.26%170.62K | 118.24%5.22K | 57.00%-7.39K | 102.19%1.2K | 102.41%10.02K |
| Effect of exchange rate changes | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 102.87%534 | 100.06%16 | --171 |
| End cash Position | -64.76%71.68K | 244.65%113.06K | 483.82%161.06K | 483.82%161.06K | 530.26%166.18K | 1,157.66%203.43K | 561.39%32.81K | -19.90%27.59K | -19.90%27.59K | -77.20%26.37K |
| Free cash from | -42.62%-261.31K | -368.73%-622.31K | -165.65%-2.29M | -1,338.90%-1.29M | -466.86%-672.67K | 53.28%-183.22K | 46.70%-132.77K | 71.58%-863.92K | -453.80%-89.74K | 83.49%-118.67K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.